AnaptysBio
ANAB
ANAB
206 hedge funds and large institutions have $1.55B invested in AnaptysBio in 2026 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 58 increasing their positions, 69 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
9% more capital invested
Capital invested by funds: $1.42B → $1.55B (+$128M)
7.8% less ownership
Funds ownership: 106.02% → 98.22% (-7.8%)
16% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 69
Holders
206
Holding in Top 10
6
Calls
$1.41M
Puts
$305K
Top Buyers
| 1 | +$26.6M | |
| 2 | +$24M | |
| 3 | +$19.9M | |
| 4 |
SAM
Synergy Asset Management
Vancouver,
Washington
|
+$17.1M |
| 5 |
ACA
Apis Capital Advisors
New York
|
+$12.8M |
Top Sellers
| 1 | -$101M | |
| 2 | -$18.2M | |
| 3 | -$8.43M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$8.08M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$6.94M |
